COVID-19 and Dermatological Manifestations

0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Coronavirus disease 2019 (COVID-19) is often associated with skin lesions. Identification of the skin lesions related to COVID-19 is important for early diagnosis and better management of affected patients. The cutaneous manifestations of COVID-19 are classified into two major categories: inflammatory lesions (maculopapular erythematous rash, papulovesicular eruption, urticarial lesions, erythema multiforme-like) and vasculopathic reaction (livedo reticularis/livedo racemosa, petechiae/noninflammatory purpura and skin necrosis, acral lesions, cutaneous small-vessel vasculitis). In addition, mucocutaneous lesions are common in multisystem inflammatory syndrome in children with COVID-19. This chapter provides a description of each entity in terms of definition, clinical and pathological manifestations, etiopathogenesis, prognosis, treatment, and differential diagnoses.

Cite

CITATION STYLE

APA

Abtahi-Naeini, B., & Fattah, M. (2021). COVID-19 and Dermatological Manifestations. In Atlas of Dermatology, Dermatopathology and Venereology: Cutaneous Infectious and Neoplastic Conditions and Procedural Dermatology (pp. 191–223). Springer International Publishing. https://doi.org/10.1007/978-3-319-53805-1_100

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free